United States securities and exchange commission logo February 1, 2022 Pam Haley Chief Financial Officer Arcadia Biosciences, Inc. 202 Cousteau Place, Suite 105 Davis, CA 95618 Re: Arcadia Biosciences, Inc. Registration Statement on Form S-1 Filed January 28, 2022 File No. 333-262407 Dear Ms. Haley: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at (202) 551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeffrey Pietsch, Esq.